trial · primary record
MST-931
Ankylosing Spondylitis (AS)
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 32 |
| Primary completion | 2027-07-30 |
| Primary endpoint | Percentage of subjects with drug related adverse events (AEs) |
| Registry ID | NCT07903493 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:29.370Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07903493
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.